- Home
- UCTT vs GHRS Comparison
UCTT vs GHRS Comparison
Compare UCTT & GHRS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- UCTT
- GHRS
- Stock Information
- Founded
- UCTT 1991
- GHRS 2018
- Country
- UCTT United States
- GHRS Ireland
- Employees
- UCTT N/A
- GHRS N/A
- Industry
- UCTT Semiconductors
- GHRS Biotechnology: Pharmaceutical Preparations
- Sector
- UCTT Technology
- GHRS Health Care
- Exchange
- UCTT Nasdaq
- GHRS Nasdaq
- Market Cap
- UCTT 1.1B
- GHRS 960.2M
- IPO Year
- UCTT 2004
- GHRS 2021
- Fundamental
- Price
- UCTT $23.95
- GHRS $14.00
- Analyst Decision
- UCTT Strong Buy
- GHRS Strong Buy
- Analyst Count
- UCTT 4
- GHRS 8
- Target Price
- UCTT $43.25
- GHRS $30.63
- AVG Volume (30 Days)
- UCTT 518.8K
- GHRS 202.6K
- Earning Date
- UCTT 07-28-2025
- GHRS 09-02-2025
- Dividend Yield
- UCTT N/A
- GHRS N/A
- EPS Growth
- UCTT N/A
- GHRS N/A
- EPS
- UCTT 0.62
- GHRS N/A
- Revenue
- UCTT $2,138,500,000.00
- GHRS N/A
- Revenue This Year
- UCTT N/A
- GHRS N/A
- Revenue Next Year
- UCTT $1.85
- GHRS N/A
- P/E Ratio
- UCTT $38.96
- GHRS N/A
- Revenue Growth
- UCTT 20.21
- GHRS N/A
- 52 Week Low
- UCTT $16.66
- GHRS $6.00
- 52 Week High
- UCTT $54.00
- GHRS $20.50
- Technical
- Relative Strength Index (RSI)
- UCTT 56.40
- GHRS 53.07
- Support Level
- UCTT $24.88
- GHRS $15.25
- Resistance Level
- UCTT $26.32
- GHRS $19.51
- Average True Range (ATR)
- UCTT 0.97
- GHRS 1.32
- MACD
- UCTT -0.07
- GHRS 0.04
- Stochastic Oscillator
- UCTT 30.83
- GHRS 28.32
About UCTT Ultra Clean Holdings Inc.
Ultra Clean Holdings Inc, through its subsidiaries, manufactures and supplies production tools, modules, and subsystems for the semiconductor capital equipment industry. The product includes precision robotic solutions, gas delivery systems, and a variety of industrial and automation production equipment products; subsystems include wafer cleaning subsystems, chemical delivery modules, top-plate assemblies, frame assemblies, and process modules. Its customer base includes firms in the semiconductor capital equipment industry, medical, energy, industrial, flat panel, and research equipment industries. It has two segments Products and Services. Its principal markets are Americas, Asia Pacific and EMEA.
About GHRS GH Research PLC
GH Research PLC is a clinical-stage biopharmaceutical company dedicated to transforming the lives of patients by developing a practice-changing treatment for depression. Its initial focus is on developing novel and proprietary mebufotenin therapies for the treatment of patients with Treatment-Resistant Depression, or TRD. Its portfolio currently includes GH001, a proprietary inhalable mebufotenin product candidate, and GH002, a proprietary intravenous mebufotenin product candidate. The group has only a single segment: Research and Development.